2LM0
 
 | | Solution structure of the AF4-AF9 complex | | Descriptor: | AF4/FMR2 family member 1/Protein AF-9 chimera | | Authors: | Leach, B.I, Kuntimaddi, A, Schmidt, C.R, Cierpicki, T, Johnson, S.A, Bushweller, J.H. | | Deposit date: | 2011-11-18 | | Release date: | 2013-01-09 | | Last modified: | 2013-01-30 | | Method: | SOLUTION NMR | | Cite: | Leukemia Fusion Target AF9 Is an Intrinsically Disordered Transcriptional Regulator that Recruits Multiple Partners via Coupled Folding and Binding.
Structure, 21, 2013
|
|
8T5X
 | | Probing the dissociation pathway of a kinetically labile transthyretin mutant (A25T) | | Descriptor: | Transthyretin | | Authors: | Ferguson, J.A, Sun, X, Leach, B.I, Stanfield, R.L, Dyson, H.J, Wright, P.E. | | Deposit date: | 2023-06-14 | | Release date: | 2023-08-02 | | Last modified: | 2024-01-17 | | Method: | X-RAY DIFFRACTION (1.63 Å) | | Cite: | Probing the Dissociation Pathway of a Kinetically Labile Transthyretin Mutant.
J.Am.Chem.Soc., 146, 2024
|
|
6B7G
 | | Solution NMR structure of BCoR in complex with AF9 (BCoR-AF9) | | Descriptor: | BCL-6 corepressor, Protein AF-9 | | Authors: | Schmidt, C.R, Kuntimaddi, A, Leach, B.I, Bushweller, J.H. | | Deposit date: | 2017-10-04 | | Release date: | 2018-10-10 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.
Blood Cancer Discov, 1, 2020
|
|
2N4Q
 | |
